Literature DB >> 2019740

Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate.

K M Wilson1, M Gerometta, D B Rylatt, P G Bundesen, D A McPhee, C J Hillyard, B E Kemp.   

Abstract

A rapid whole blood test has been developed for circulating antibodies to human immunodeficiency virus type 1 (HIV-1), based on agglutination of autologous red blood cells. Evaluation of the test revealed that 100% of seropositive HIV-1 patients (both asymptomatic and AIDS cases) were detected (n = 94) with a specificity of 99.5% in healthy blood donors (n = 596). The assay uses an Fab fragment of a monoclonal antibody specifically directed against glycophorin (a transmembrane glycoprotein present on the surface of human red blood cells). This anti-red blood cell Fab is conjugated via the inter-heavy chain cysteines to a synthetic peptide corresponding to the immunodominant epitope of the HIV-1 viral coat protein gp41 (579-613). Addition of this reagent to 10 microliters of whole blood results in the Fab-peptide conjugate coating the red blood cells with peptide. In the presence of circulating antibodies to the HIV-1 peptide, red cell agglutination occurs within 2 min. The sensitivity and specificity of this reagent indicate that it is appropriate for use as a rapid diagnostic test for HIV-1 seropositivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019740     DOI: 10.1016/0022-1759(91)90070-v

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence.

Authors:  S Sirivichayakul; P Phanuphak; S Tanprasert; S Thanomchat; C Uneklabh; T Phutiprawan; C Mungklavirat; Y Panjurai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

2.  A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.

Authors:  Robert L Kruse; Yuting Huang; Heather Smetana; Eric A Gehrie; Timothy K Amukele; Aaron A R Tobian; Heba H Mostafa; Zack Z Wang
Journal:  Biochem Biophys Res Commun       Date:  2021-03-15       Impact factor: 3.575

Review 3.  Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.

Authors:  Jody Hobson-Peters
Journal:  J Biomed Biotechnol       Date:  2012-04-18

4.  Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?

Authors:  Daniele Focosi; Massimo Franchini; Fabrizio Maggi
Journal:  Vaccines (Basel)       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.